WallSt.net Announces Upcoming Interview With CEO of Avicena Group

NEW YORK, Dec. 6  /PRNewswire-FirstCall/ -- Dr. Belinda Tsao-Nivaggioli, Chief Executive Officer of Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO)  (http://www.avicenagroup.com/) will be featured in an exclusive interview with http://www.wallst.net/ scheduled for December 10 at 5 p.m. EST. The interview will be posted on http://www.wallst.net/ by 8 p.m. EST on December 10.

The interview will cover topics including Avicena Group's market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net/ and click on "Interviews." The interview can be accessed by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window.

About Avicena Group:

Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO)  is a Palo Alto, California based late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases. The Company's core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena's pharmaceutical program centers on rare neurological disorders (orphan diseases). Near term, the Company plans to initiate a confirmatory Phase III trial in ALS and a Phase III trial in Huntington's disease to accompany the ongoing NIH Phase III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

  For more information, please visit http://www.avicenagroup.com/.

  About WallSt.net:


http://www.wallst.net/ is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Website is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net/, a financial social network for investors, Financial Filings Corp., a provider of compliance solutions to publicly traded companies, and WallStRadio, a business and finance podcast Website. Financial Filings Corp. is expecting to receive two hundred eighty dollars from Avicena Group, Inc. for the dissemination of this press release. For a complete list of our advertisers and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact:  WallSt.net

800-4-WALL-ST 

DATASOURCE: Financial Filings Corp.



CONTACT:  WallSt.net, 1-800-4-WALL-ST



Web site:  http://www.wallst.net/

http://www.avicenagroup.com/ 

Copyright